The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group of researchers. The ...
SAN DIEGO, Feb. 18, 2025 /PRNewswire/ -- Alume Biosciences, a late-clinical stage biotechnology company developing nerve illuminating technology to potentially make surgery safer, today announced the ...
SAN DIEGO, CA, UNITED STATES, February 16, 2026 /EINPresswire.com/ — Alume Biosciences, a clinical-stage biotechnology company advancing precision imaging agents ...
LA JOLLA, Calif., May 1, 2020 /PRNewswire/ -- Alume Biosciences, Inc., a privately held biotechnology company developing nerve-targeted pharmaceuticals for surgical and therapeutic use, today ...
Alume Biosciences delivers positive topline results for three pivotal trials of Bevonescein, advancing toward NDA submission with US FDA in 2H 2026 Even with meticulous technique, surgeons are limited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results